Search Results - "House, Karen W." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids

by Bleecker, Eugene R., MD, Bateman, Eric D., MD, Busse, William W., MD, Woodcock, Ashley, MD, Frith, Lucy, MSc, House, Karen W., MS, Jacques, Loretta, PhD, Davis, Angela M., MD, Haumann, Brett, MD, Lötvall, Jan, MD, PhD
Published in Annals of allergy, asthma, & immunology (01.11.2012)

Get full text

Journal Article

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products

by Daley-Yates, Peter T., PhD, Parkins, David A., PhD, Thomas, Marian J., PhD, Gillett, Benjamin, BSc, House, Karen W., MS, Ortega, Hector G., MD, ScD
Published in Clinical therapeutics (01.02.2009)

Get full text

Journal Article

Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study

Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study

by Cowie, Robert L., MD, Boulet, Louis-Philippe, MD, Keith, Paul K., MD, Scott-Wilson, Catherine A, House, Karen W, Dorinsky, Paul M., MD
Published in Clinical therapeutics (01.07.2007)

Get full text

Journal Article

Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma

Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma

by LaForce, C F, Pearlman, D S, Ruff, M E, Silvers, W S, Weinstein, S W, Clements, D S, Brown, A, Duke, S, Harding, S M, House, K W
Published in Annals of allergy, asthma, & immunology (01.11.2000)

Get more information

Journal Article

Letter to the editor

Letter to the editor

by Daley-Yates, Peter T, Parkins, David A, Thomas, Marian J, Gillett, Benjamin, House, Karen W, Ortega, Hector G
Published in Clinical therapeutics (01.05.2010)

Get full text

Journal Article

PII: S0149-2918(10)00182-7

PII: S0149-2918(10)00182-7

by Daley-Yates, Peter T., Parkins, David A., Thomas, Marian J., Gillett, Benjamin, House, Karen W., Ortega, Hector G.
Published in Clinical therapeutics (2010)

Get full text

Journal Article

Letter to the editor

Letter to the editor

by Daley-Yates, Peter T, Parkins, David A, Thomas, Marian J, Gillett, Benjamin, House, Karen W, Ortega, Hector G
Published in Clinical therapeutics (01.12.2009)

Get full text

Journal Article

Letter to the Editor

Letter to the Editor

by Daley-Yates, Peter T, Parkins, David A, Thomas, Marian J, Gillett, Benjamin, House, Karen W, Ortega, Hector G
Published in Clinical therapeutics (01.08.2009)

Get full text

Journal Article

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 [mu]g and fluticasone propionate 250 [mu]g: Implications for establishing bioequivalence of inhaled products

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 [mu]g and fluticasone propionate 250 [mu]g: Implications for establishing bioequivalence of inhaled products

by Daley-Yates, Peter T, Parkins, David A, Thomas, Marian J, Gillett, Benjamin, House, Karen W, Ortega, Hector G
Published in Clinical therapeutics (01.02.2009)

Get full text

Journal Article

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products

by Daley-Yates, Peter T, Parkins, David A, Thomas, Marian J, Gillett, Benjamin, House, Karen W, Ortega, Hector G
Published in Clinical therapeutics (01.02.2009)

Get full text

Journal Article

PII: S0149-2918(09)00315-4

PII: S0149-2918(09)00315-4

by Daley-Yates, Peter T., Parkins, David A., Thomas, Marian J., Gillett, Benjamin, House, Karen W., Ortega, Hector G.
Published in Clinical therapeutics (2009)

Get full text

Journal Article

Pharmacokinetic, Pharmacodynamic, Efficacy, and Safety Data From Two Randomized, Double-Blind Studies in Patients With Asthma and an In Vitro Study Comparing Two Dry-Powder Inhalers Delivering a Combination of Salmeterol 50 pg and Fluticasone Propionate 250 μg : Implications for Establishing Bioequivalence of Inhaled Products

Pharmacokinetic, Pharmacodynamic, Efficacy, and Safety Data From Two Randomized, Double-Blind Studies in Patients With Asthma and an In Vitro Study Comparing Two Dry-Powder Inhalers Delivering a Combination of Salmeterol 50 pg and Fluticasone Propionate 250 μg : Implications for Establishing Bioequivalence of Inhaled Products

by DALEY-YATES, Peter T, PARKINS, David A, THOMAS, Marian J, GILLETT, Benjamin, HOUSE, Karen W, ORTEGA, Hector G
Published in Clinical therapeutics (2009)

Get full text

Journal Article

PII: S0149-2918(09)00485-8

PII: S0149-2918(09)00485-8

by Daley-Yates, Peter T., Parkins, David A., Thomas, Marian J., Gillett, Benjamin, House, Karen W., Ortega, Hector G.
Published in Clinical therapeutics (2009)

Get full text

Journal Article

Letter to the editor

Letter to the editor

by Daley-Yates, Peter T., PhD, Parkins, David A., PhD, Thomas, Marian J., PhD, Gillett, Benjamin, BSc, House, Karen W., MS, Ortega, Hector G., MD, ScD
Published in Clinical therapeutics (2010)

Get full text

Journal Article

Letter to the editor

Letter to the editor

by Daley-Yates, Peter T., PhD, Parkins, David A., PhD, Thomas, Marian J., PhD, Gillett, Benjamin, BSc, House, Karen W., MS, Ortega, Hector G., ScD
Published in Clinical therapeutics (2009)

Get full text

Journal Article

Letter to the Editor

Letter to the Editor

by Daley-Yates, Peter T., PhD, Parkins, David A., PhD, Thomas, Marian J., PhD, Gillett, Benjamin, BSc, House, Karen W., MS, Ortega, Hector G., MD, ScD
Published in Clinical therapeutics (2009)

Get full text

Journal Article

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma

by Peden, David B., Berger, William E., Noonan, Michael J., Thomas, M.Ross, Hendricks, Virginia L., Hamedani, Abbas G., Mahajan, Puneet, House, Karen W.
Published in Journal of allergy and clinical immunology (01.07.1998)

Get full text

Journal Article

Fluticasone propionate/salmeterol diskus combination product improves asthma-related quality of life compared with individual components in asthma patients symptomatic on [beta]2 agonists alone

Fluticasone propionate/salmeterol diskus combination product improves asthma-related quality of life compared with individual components in asthma patients symptomatic on [beta]2 agonists alone

by Edin, Heather M, Lang, Melissa L, van dermeer, Anna K, House, Karen W, Shah, Tushar P
Published in Journal of allergy and clinical immunology (01.01.2002)

Get full text

Journal Article

Fluticasone propionate/salmeterol diskus combination product improves asthma-related quality of life compared with individual components in asthma patients symptomatic on β 2 agonists alone

Fluticasone propionate/salmeterol diskus combination product improves asthma-related quality of life compared with individual components in asthma patients symptomatic on β 2 agonists alone

by Edin, Heather M, Lang, Melissa L, Vandermeer, Anna K, House, Karen W, Shah, Tushar P
Published in Journal of allergy and clinical immunology (2002)

Get full text

Journal Article

Fluticasone propionate/salmeterol diskus combination product improves asthma-related quality of life compared with individual components in asthma patients symptomatic on β2 agonists alone

Fluticasone propionate/salmeterol diskus combination product improves asthma-related quality of life compared with individual components in asthma patients symptomatic on β2 agonists alone

by Edin, Heather M, Lang, Melissa L, Vandermeer, Anna K, House, Karen W, Shah, Tushar P
Published in Journal of allergy and clinical immunology (01.01.2002)

Get full text

Journal Article